Ultragenyx Pharmaceutical
RARE
RARE
240 hedge funds and large institutions have $6.24B invested in Ultragenyx Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 78 increasing their positions, 89 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
19% less capital invested
Capital invested by funds: $7.73B → $6.24B (-$1.49B)
22% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 55
Holders
240
Holding in Top 10
–
Calls
$6.38M
Puts
$7.52M
Top Buyers
| 1 | +$87M | |
| 2 | +$57.2M | |
| 3 | +$56M | |
| 4 |
Millennium Management
New York
|
+$53.7M |
| 5 |
ClearBridge Investments
New York
|
+$44.5M |
Top Sellers
| 1 | -$267M | |
| 2 | -$188M | |
| 3 | -$39.9M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$36.9M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$24.9M |